Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs-Reference-Cited by-同舟云学术

Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs

Published:2014-04 Issue:2 Volume:14 Page:148-154
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Martino Massimo^ORCID,Postorino Maurizio,Gallo Giuseppe Alberto,Messina Giuseppe,Neri Santo,Piro Eugenio,Gentile Massimo,Moscato Tiziana,Monteleone Renza,Fedele Roberta,Mazzone Carla,Console Giuseppe,Penna Giuseppa,Alati Caterina,Vincelli Iolanda Donatella,Irrera Giuseppe,Musolino Caterina,Ronco Francesca,Molica Stefano,Morabito Fortunato

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference42 articles.

1. Doublets, triplets, or quadruplets of novel agents in newly diagnosed myeloma?;Rajkumar;Hematol Am Soc Hematol Educ Program,2012

2. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative;Gertz;Mayo Clin Proc,2008

3. VAD-based regimens as primary treatment for multiple myeloma;Alexanian;Am J Hematol,1990

4. The role of complete response in multiple myeloma;Harousseau;Blood,2009

5. Autologous hematopoietic stem cell transplantation for multiple myeloma;Harousseau;N Engl J Med,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma;Frontiers in Oncology;2022-07-05

2. Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma;Drug Design, Development and Therapy;2021-07

3. Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period;Annals of Hematology;2020-05-07

4. Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma;Leukemia;2020-04-23

5. Toxicities, response and survival: Autologous stem cell transplantation for multiple myeloma over 25 years at a single center;Cancer Treatment and Research Communications;2017